Is CNC Banking on Membership Growth to Boost Scale & Profitability?
Centene is delivering solid membership expansion through strong Marketplace and Medicare PDP enrollment, a widened Medicare Advantage presence via its WellCare platform—introducing plans in new counties—upgraded star ratings, innovative benefit features, and focused local and regional growth and retention strategies. Contract wins and market expansion further support medical membership gains. Although Medicaid enrollment has softened, total membership reached 28 million as of June 30, 2025, driven by growth in Marketplace, Individual and Commercial Group, Medicare, and Medicare PDP plans.
Membership growth strengthens Centene's scale, profitability and resilience, enabling it to manage market uncertainty with a diverse payer mix and strong positions in government-sponsored programs. While Medicaid provides relative stability, Medicare Advantage offers rapid expansion potential. With healthcare costs trending upward, ongoing membership momentum—fueled by product innovation, geographic reach and community-focused retention—remains a key driver of Centene's sustained earnings power and competitive advantage.
What About its Peers?
Humana Inc. HUM continues to grow its membership, fueled by Medicare Advantage and state-based programs. As of June 30, 2025, 68% of Humana's 3,542,300 individual Medicare Advantage members were in value-based care. Humana projects a 175,000-250,000 increase in state-based contract membership in 2025.
UnitedHealth Group UNH is seeing robust growth in medical membership, fueled by strong demand for commercial and government-supported health plans. UnitedHealth's vertically integrated model delivers coordinated, value-based care, appealing to seniors and employer-sponsored members. To maintain growth, UnitedHealth must emphasize strategic planning and enforce disciplined cost management across its operations.
CNC's Price Performance
Shares of CNC have lost 55.3% year to date, underperforming the industry.
CNC's Cheap Valuation
CNC trades at a forward 12-month price-to-earnings of 7.2, below the industry average of 12.1.
Estimate Movements for CNC
The Zacks Consensus Estimate for CNC's third-quarter and fourth-quarter 2025 EPS witnessed a southward revision over the past seven days. The consensus estimate for full-year 2025 and 2026 EPS also followed suit.
The consensus estimate for CNC's 2025 revenues indicates a year-over-year increase but the same for EPS suggests a decline. For 2026, the case is exactly the opposite.
CNC stock currently carries a Zacks Rank #5 (Strong Sell).
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report
Humana Inc. (HUM): Free Stock Analysis Report
Centene Corporation (CNC): Free Stock Analysis Report
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
3 minutes ago
- CTV News
Bad diets, too many meds, no exercise: A look inside the latest ‘Make America Healthy Again' report
Savannah Knott hangs up her backpack for the day on the first day in her second grade classroom at Mary Carrico Catholic School, Tuesday, Aug. 12, 2025, in Knottsville, Ky. (Greg Eans/The Messenger-Inquirer via AP) WASHINGTON — A report that U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has promised will improve the health of America's children does not call on the government to make significant changes to its food or farming policies, according to a draft document obtained by The Associated Press. The 'Make America Healthy Again' strategy report is supposed to be one of Kennedy's signature achievements as the nation's health secretary, giving the government a roadmap to help its citizens lose weight, reduce chronic diseases and exercise more. Before coming to Washington, Kennedy had spent much of his career decrying the harms of chemicals sprayed on crops, prescription drugs, ultraprocessed foods, and vaccines. His coalition, then, has expected him to take bold action as the nation's top health leader. But a draft of the so-called 'MAHA' report, first reported by The New York Times Thursday night, mostly calls on the government to further study chronic diseases, bad air quality, Americans' diets and prescription drug use. The report lays out four problem areas – poor diet, chemical exposure, lack of physical activity and overuse of medications -- that are to blame for chronic diseases in the U.S. The White House has held off on publicly releasing the report, which was submitted to U.S. President Donald Trump on Tuesday. The latest report is the policy companion to a 'MAHA' report released in May, which was found to have several errors in it. White House spokesman Kush Desai refused to confirm whether the copy obtained by the Associated Press was a final version, though HHS officials have insisted the report has been finalized since Tuesday. 'President Trump pledged to Make America Healthy Again, and the Administration is committed to delivering on that pledge with Gold Standard Science,' Desai said. 'Until officially released by the White House and MAHA Commission, however, any documents purporting to be the second MAHA Report should be considered as nothing more than speculative literature.' Some in the agricultural industry had warily anticipated the report, fearing it would call for bans or investigations into the use of pesticides and herbicides that farmers in the U.S. regularly spray on crops to control weeds and enhance yields. Other farmers were concerned about how the report may target the use of corn syrup, a common sweetener, in American foods. Both products have been a central talking point in Kennedy's 'MAHA' movement, which has attracted a diverse coalition of suburban and rural moms, Trump supporters and liberals concerned about the nation's food supply. Instead, the report calls for an 'awareness' campaign to raise confidence in pesticides. Concerns from the agricultural industry waned as the report hit the president's desk, with one of Kennedy's closest advisers, Calley Means, calling for MAHA supporters to work with major farm companies on Tuesday. Means also acknowledged that the 'pace of political change' can be frustrating. 'We need to build bridges,' Means said, adding that: 'We are not going to win if the soybean farmers and the corn growers are our enemy.' Means did not respond to a request for comment on Friday. A spokesman for Kennedy also declined to comment. The report urges the National Institutes of Health – which is facing a 40 per cent cut to its budget under the Trump administration – to undertake several studies on Americans' health, including research on vaccine injury, autism, air quality, water quality, prescription drugs, and nutrition. The report also calls for changes to the foods served in schools and hospitals, something that will be hard to deliver with the Trump administration's funding cuts, said Kari Hamerschlag, the deputy director of the food and agriculture at the nonprofit Friends of the Earth. Earlier this year, the Republican-led administration wiped out US$1 billion set aside that helped food banks and schools procure food directly from local farmers. 'This is not going to transform our food and farming system,' Hamerschlag said. 'This is not going to make people healthier. They need to put resources behind their recommendations.' ___ Amanda Seitz, The Associated Press
Globe and Mail
21 minutes ago
- Globe and Mail
Best Stock to Buy: Eli Lilly Stock vs. Novo Nordisk Stock
(NYSE: LLY) and Novo Nordisk (NYSE: NVO) are competing in the market for weight loss and diabetes treatments. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » *Stock prices used were the afternoon prices of Aug. 9, 2025. The video was published on Aug. 11, 2025. Should you invest $1,000 in Eli Lilly right now? Before you buy stock in Eli Lilly, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 11, 2025 Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Globe and Mail
21 minutes ago
- Globe and Mail
Bank of America Securities Remains a Buy on Advanced Micro Devices (AMD)
Bank of America Securities analyst Vivek Arya maintained a Buy rating on Advanced Micro Devices yesterday and set a price target of $200.00. The company's shares closed yesterday at $184.42. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Arya covers the Technology sector, focusing on stocks such as Nvidia, ON Semiconductor, and Advanced Micro Devices. According to TipRanks, Arya has an average return of 18.8% and a 61.68% success rate on recommended stocks. In addition to Bank of America Securities, Advanced Micro Devices also received a Buy from Mizuho Securities's Vijay Rakesh in a report issued yesterday. However, on August 12, Citi reiterated a Hold rating on Advanced Micro Devices (NASDAQ: AMD). See Insiders' Hot Stocks on TipRanks >> Based on Advanced Micro Devices' latest earnings release for the quarter ending June 28, the company reported a quarterly revenue of $7.69 billion and a net profit of $872 million. In comparison, last year the company earned a revenue of $5.84 billion and had a net profit of $265 million Based on the recent corporate insider activity of 54 insiders, corporate insider sentiment is neutral on the stock. Earlier this month, PAUL DARREN GRASBY, the EVP & CSO of AMD sold 10,000.00 shares for a total of $1,732,100.00.
